Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125349931 | 12534993 | 1 | I | 20160705 | 20160707 | 20160707 | EXP | JP-009507513-1607JPN001940 | MERCK | 44.00 | YR | F | Y | 0.00000 | 20160707 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125349931 | 12534993 | 1 | PS | CASPOFUNGIN ACETATE | CASPOFUNGIN ACETATE | 1 | U | 21227 | INJECTION | ||||||||||
| 125349931 | 12534993 | 2 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | U | 0 | |||||||||||
| 125349931 | 12534993 | 3 | SS | amphotericin B (+) cholesterol (+) distearoylphosphatidylglycerol (+) | AMPHOTERICIN BCHOLESTEROL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125349931 | 12534993 | 1 | Bronchopulmonary aspergillosis |
| 125349931 | 12534993 | 2 | Bronchopulmonary aspergillosis |
| 125349931 | 12534993 | 3 | Bronchopulmonary aspergillosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125349931 | 12534993 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125349931 | 12534993 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |